A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss - CNBC

A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss - CNBC
Why breakthrough GLP-1 weight loss pills may be a bad thing for employer insurance coverage
As the GLP-1 race heats up, how can investors position themselves for the next wave of innovation? (LLY:NYSE) - Seeking Alpha
Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage - CNBC
Amazon launches GLP-1 weight loss program, promising'fast, convenient' access
Eli Lilly taps into its GLP-1 windfall, while Honeywell sheds a lower-margin unit
1.64BUSD
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US37946R1095
CUSIP
37946R109
Sector
Energy
Industry
Oil & Gas Midstream
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
13.43
PEG Ratio
6.18
Book Value
18.71
Dividend Share
3.03
Dividend Yield
6.31%
Earnings Share
3.6
Wall Street Target Price
45.50
EPS Estimate Current Year
4.71
EPS Estimate Next Year
3.71
EPS Estimate Current Quarter
0.33
EPS Estimate Next Quarter
0.92
Most Recent Quarter
-
Revenue TTM
19,291,023,360
Gross Profit TTM
1,194,296,064
EBITDA
422,752,000
Profit Margin
0.67%
Return On Assets TTM
4.31%
Return On Equity TTM
21.24%
Revenue Per Share TTM
569.54
Qtly Revenue Growth YOY
15.90%
Diluted Eps TTM
3.6
Qtly Earnings Growth YOY
413.90%
Trailing PE
13.43
Forward PE
14
Price Sales TTM
0.0851
Price Book MRQ
2.3067
Enterprise Value Revenue
0
Enterprise Value EBITDA
9
75.98
1.99%56.12
1.87%68.94
1.53%283.00
1.27%32.50
0.71%14.45
0.00%37.50
-2.10%56.54
-1.12%20.08
-0.52%91.90
-0.29%